SAI-CHING J YEUNG to Cell Line, Tumor
This is a "connection" page, showing publications SAI-CHING J YEUNG has written about Cell Line, Tumor.
Connection Strength
0.512
-
Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. Cell Cycle. 2012 Jun 15; 11(12):2314-26.
Score: 0.036
-
The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med. 2011 Apr; 15(4):825-36.
Score: 0.033
-
Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biol Ther. 2008 Oct; 7(10):1679-84.
Score: 0.028
-
Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model. J Clin Endocrinol Metab. 2007 Aug; 92(8):2902-9.
Score: 0.026
-
Redox control of manumycin A-induced apoptosis in anaplastic thyroid cancer cells: involvement of the xenobiotic apoptotic pathway. Cancer Biol Ther. 2006 Mar; 5(3):275-80.
Score: 0.024
-
Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer. Surgery. 2005 Sep; 138(3):456-63.
Score: 0.023
-
Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells. Cancer Res. 2005 May 01; 65(9):3671-81.
Score: 0.022
-
Bcl-2-associated X protein is the main mediator of manumycin a-induced apoptosis in anaplastic thyroid cancer cells. J Clin Endocrinol Metab. 2005 Jun; 90(6):3583-91.
Score: 0.022
-
PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET. Cancer Lett. 2023 07 28; 567:216283.
Score: 0.019
-
Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. Oncogene. 2021 03; 40(11):1974-1987.
Score: 0.017
-
Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clin Cancer Res. 2020 09 15; 26(18):4921-4932.
Score: 0.016
-
Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma. Clin Cancer Res. 2019 05 15; 25(10):3035-3045.
Score: 0.014
-
The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma. Cancer Med. 2018 10; 7(10):5205-5216.
Score: 0.014
-
Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity. PLoS One. 2017; 12(11):e0188025.
Score: 0.013
-
Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis. J Pathol. 2017 03; 241(4):448-462.
Score: 0.013
-
Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun. 2016 10 06; 7:13007.
Score: 0.012
-
Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res. 2015 Nov 15; 75(22):4708-17.
Score: 0.011
-
TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma. Oncotarget. 2015 Sep 15; 6(27):24163-77.
Score: 0.011
-
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res. 2015 Oct 01; 75(19):4131-42.
Score: 0.011
-
ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development. Cancer Cell. 2015 Aug 10; 28(2):183-97.
Score: 0.011
-
The cell cycle regulator 14-3-3s opposes and reverses cancer metabolic reprogramming. Nat Commun. 2015 Jul 16; 6:7530.
Score: 0.011
-
CSN6 deregulation impairs genome integrity in a COP1-dependent pathway. Oncotarget. 2015 May 20; 6(14):11779-93.
Score: 0.011
-
CSN6 drives carcinogenesis by positively regulating Myc stability. Nat Commun. 2014 Nov 14; 5:5384.
Score: 0.011
-
Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma. Oncol Rep. 2014 Jun; 31(6):2579-86.
Score: 0.010
-
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death Dis. 2014 Feb 27; 5:e1088.
Score: 0.010
-
CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle. 2013 Mar 15; 12(6):935-43.
Score: 0.010
-
CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle. 2012 Dec 15; 11(24):4633-41.
Score: 0.009
-
HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle. 2012 Nov 15; 11(22):4181-90.
Score: 0.009
-
Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor a and bcr-abl oncogene addiction in malignant hematologic cells. Clin Cancer Res. 2012 Apr 01; 18(7):1966-78.
Score: 0.009
-
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest. 2011 Mar; 121(3):851-65.
Score: 0.008
-
14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res. 2011 Feb 01; 71(3):884-94.
Score: 0.008
-
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res. 2010; 12(6):R96.
Score: 0.008
-
Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene. 2009 Jul 16; 28(28):2581-92.
Score: 0.007
-
Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res. 2007 Jan 01; 13(1):234-40.
Score: 0.006
-
Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics. 2003 Oct; 3(10):1904-11.
Score: 0.005